Company Research Report: Zurex Pharma

Company Overview

• Name: Zurex Pharma

• Mission: Advancing the science of skin antisepsis.

• Foundation Details: No information is available about the founding year and founders.

• Key People: No information is available.

• Headquarters: 2113 Eagle Drive, Middleton, WI 53562

• Number of Employees: No information is available.

• Revenue: No information is available.

• Company Specialty: Zurex Pharma is known for their innovative work in skin antisepsis, particularly focusing on products that offer effective microbial reduction with minimized skin irritation.

Products

ZuraGard

Description

ZuraGard is designed to provide unsurpassed protection to patients and expedite the process for medical practitioners. Its innovative design aims to optimize the application process while ensuring effective antiseptic protection.

Key Features

• Faster Application: The ZuraGard applicator rapidly saturates the sponge tip, engineered specifically to reduce preparation time significantly compared to competitors in the market.

• Ease of Use: Features a patented hourglass design along with thumb-guide activation, allowing for easy one-hand application. This design is highlighted in a 2020 end-user survey for its user-friendliness.

• Safety: Clinical trials indicated ZuraGard shows less skin irritation and superior microbial reduction compared to a typical 2% w/v CHG/70% v/v Isopropyl Alcohol product.

• Antimicrobial Efficacy: Conducted two Phase 2 studies demonstrating immediate and long-lasting antimicrobial activity with no adverse skin reactions.

• Different Applicator Colors: Available in three colors to provide options based on patient’s skin tone, enhancing confidence in coverage.

• Multiple Sizes: Available in 26 mL and 10.5 mL, with indications of new options coming soon.

Recent Developments

• Product Efficacy Studies: ZuraGard has been the subject of multiple Phase 3 pivotal efficacy studies comparing it to existing market products. These studies have supported its effectiveness, achieving targeted microbial reductions at various time intervals post-application.

• No Observed Adverse Effects: The product demonstrated immediate antiseptic activity with no observable adverse effects during trials.

• Coming Soon Products: Additional product sizes or other related developments have been indicated as forthcoming.

Summary

Zurex Pharma is committed to advancing skin antisepsis with innovative solutions like ZuraGard, which is specifically engineered for rapid, easy, and safe application. While the company holds a strong position in the antisepsis market, detailed insights regarding its broader strategic initiatives remain undisclosed.